{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:53:23Z","timestamp":1782276803159,"version":"3.54.5"},"reference-count":62,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","award":["MRC0161"],"award-info":[{"award-number":["MRC0161"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sandoz Limited UK","award":["1010180"],"award-info":[{"award-number":["1010180"]}]},{"DOI":"10.13039\/100010381","name":"European Society for Paediatric Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR300098"],"award-info":[{"award-number":["NIHR300098"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Growth hormone insensitivity (GHI) in children is characterized by short stature, functional insulin-like growth factor (IGF)-I deficiency, and normal or elevated serum growth hormone (GH) concentrations. The clinical and genetic etiology of GHI is expanding.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We undertook genetic characterization of short stature patients referred with suspected GHI and features which overlapped with known GH\u2013IGF-I axis defects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between 2008 and 2020, our center received 149 GHI referrals for genetic testing. Genetic analysis utilized a combination of candidate gene sequencing, whole exome sequencing, array comparative genomic hybridization, and a targeted whole genome short stature gene panel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Genetic diagnoses were identified in 80\/149 subjects (54%) with 45\/80 (56%) having known GH\u2013IGF-I axis defects (GHR n\u2005=\u200540, IGFALS n\u2005=\u20054, IGFIR n\u2005=\u20051). The remaining 35\/80 (44%) had diagnoses of 3M syndrome (n\u2005=\u200510) (OBSL1 n\u2005=\u20057, CUL7 n\u2005=\u20052, and CCDC8 n\u2005=\u20051), Noonan syndrome (n\u2005=\u20054) (PTPN11 n\u2005=\u20052, SOS1 n\u2005=\u20051, and SOS2 n\u2005=\u20051), Silver\u2013Russell syndrome (n\u2005=\u20052) (loss of methylation on chromosome 11p15 and uniparental disomy for chromosome 7), Class 3-5 copy number variations (n\u2005=\u200510), and disorders not previously associated with GHI (n\u2005=\u20059) (Barth syndrome, autoimmune lymphoproliferative syndrome, microcephalic osteodysplastic primordial dwarfism type II, achondroplasia, glycogen storage disease type IXb, lysinuric protein intolerance, multiminicore disease, macrocephaly, alopecia, cutis laxa, and scoliosis syndrome, and Bloom syndrome).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We report the wide range of diagnoses in 149 patients referred with suspected GHI, which emphasizes the need to recognize GHI as a spectrum of clinical entities in undiagnosed short stature patients. Detailed clinical and genetic assessment may identify a diagnosis and inform clinical management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab437","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:09:25Z","timestamp":1623888565000},"page":"e4716-e4733","source":"Crossref","is-referenced-by-count":18,"title":["Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-657X","authenticated-orcid":false,"given":"Afiya","family":"Andrews","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8051-3866","authenticated-orcid":false,"given":"Avinaash","family":"Maharaj","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-6547","authenticated-orcid":false,"given":"Emily","family":"Cottrell","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4402-8297","authenticated-orcid":false,"given":"Pratik","family":"Shah","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Denvir","sequence":"additional","affiliation":[{"name":"Nottingham University Hospital, Nottinghamshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Dumic","sequence":"additional","affiliation":[{"name":"University Hospital Centre, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Bossowski","sequence":"additional","affiliation":[{"name":"Department of Peadiatrics, Endocrinology and Diabetes with a Cardiology Unit, Medical University of Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat","family":"Mushtaq","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rade","family":"Vukovic","sequence":"additional","affiliation":[{"name":"Mother and Child Health Care Institute of Serbia, \u201cDr Vukan Cupic\u201d, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Didi","sequence":"additional","affiliation":[{"name":"Alder Hey Children\u2019s Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Shaw","sequence":"additional","affiliation":[{"name":"Birmingham Children\u2019s Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A","family":"Metherell","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-3376","authenticated-orcid":false,"given":"Martin O","family":"Savage","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-1931","authenticated-orcid":false,"given":"Helen L","family":"Storr","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"issue":"7","key":"2021120108534909400_CIT0001","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ncpendmet0195","article-title":"Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders","volume":"2","author":"Savage","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"2021120108534909400_CIT0002","article-title":"Disorders of growth hormone in childhood","volume-title":"Endotext.","author":"Murray","year":"2000"},{"issue":"1","key":"2021120108534909400_CIT0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000502231","article-title":"Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective","volume":"92","author":"Collett-Solberg","year":"2019","journal-title":"Horm Res Paediatr."},{"issue":"4","key":"2021120108534909400_CIT0004","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1210\/er.2010-0023","article-title":"Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity","volume":"32","author":"David","year":"2011","journal-title":"Endocr Rev."},{"issue":"4","key":"2021120108534909400_CIT0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1020905725012","article-title":"Growth hormone insensitivity (Laron syndrome)","volume":"3","author":"Laron","year":"2002","journal-title":"Rev Endocr Metab Disord."},{"issue":"3","key":"2021120108534909400_CIT0006","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jc.2003-031033","article-title":"Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003","volume":"89","author":"Laron","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021120108534909400_CIT0007","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/ijms19051433","article-title":"Growth hormone receptor mutations related to individual dwarfism","volume":"19","author":"Lin","year":"2018","journal-title":"Int J Mol Sci."},{"issue":"20","key":"2021120108534909400_CIT0008","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1073\/pnas.86.20.8083","article-title":"Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism","volume":"86","author":"Godowski","year":"1989","journal-title":"Proc Natl Acad Sci u s a."},{"issue":"1","key":"2021120108534909400_CIT0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0597-13","article-title":"A dominant-negative mutation of the growth hormone receptor causes familial short stature","volume":"16","author":"Ayling","year":"1997","journal-title":"Nat Genet."},{"issue":"4","key":"2021120108534909400_CIT0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/cen.13116","article-title":"A novel dominant negative mutation in the intracellular domain of GHR is associated with growth hormone insensitivity","volume":"85","author":"Takagi","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2021120108534909400_CIT0011","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/js.2016-1119","article-title":"Novel dominant-negative GH receptor mutations expands the spectrum of GHI and IGF-I deficiency","volume":"1","author":"Vairamani","year":"2017","journal-title":"j Endocr Soc."},{"issue":"3","key":"2021120108534909400_CIT0012","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/323266","article-title":"Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity","volume":"69","author":"Metherell","year":"2001","journal-title":"Am j Hum Genet."},{"issue":"2","key":"2021120108534909400_CIT0013","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1210\/jc.2006-1527","article-title":"An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes","volume":"92","author":"David","year":"2007","journal-title":"j Clin Endocrinol Metab."},{"key":"2021120108534909400_CIT0014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2015.12.006","article-title":"STAT5B deficiency: Impacts on human growth and immunity","volume":"28","author":"Hwa","year":"2016","journal-title":"Growth Horm igf Res."},{"issue":"18","key":"2021120108534909400_CIT0015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","author":"Woods","year":"1996","journal-title":"n Engl j Med."},{"issue":"4","key":"2021120108534909400_CIT0016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa1415227","article-title":"Paternally inherited IGF2 mutation and growth restriction","volume":"373","author":"Begemann","year":"2015","journal-title":"n Engl j Med."},{"issue":"6","key":"2021120108534909400_CIT0017","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa013100","article-title":"Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene","volume":"350","author":"Domen\u00e9","year":"2004","journal-title":"n Engl j Med."},{"issue":"4","key":"2021120108534909400_CIT0018","doi-asserted-by":"crossref","first-page":"363","DOI":"10.15252\/emmm.201506106","article-title":"Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability","volume":"8","author":"Dauber","year":"2016","journal-title":"embo Mol Med."},{"key":"2021120108534909400_CIT0019","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fendo.2011.00095","article-title":"Genetic defects in the growth hormone-IGF-I axis causing growth hormone insensitivity and impaired linear growth","volume":"2","author":"Savage","year":"2011","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"2021120108534909400_CIT0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/er.2018-00146","article-title":"Nonclassical GH insensitivity: characterization of mild abnormalities of GH action","volume":"40","author":"Storr","year":"2019","journal-title":"Endocr Rev."},{"key":"2021120108534909400_CIT0021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ghir.2017.12.004","article-title":"Genetic disorders of GH action pathway","volume":"38","author":"Domen\u00e9","year":"2018","journal-title":"Growth Horm IGF Res."},{"key":"2021120108534909400_CIT0022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ghir.2015.11.005","article-title":"Atypical defects resulting in growth hormone insensitivity","volume":"28","author":"Wit","year":"2016","journal-title":"Growth Horm igf Res."},{"issue":"4","key":"2021120108534909400_CIT0023","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/EJE-15-0937","article-title":"Mechanisms in endocrinology: novel genetic causes of short stature","volume":"174","author":"Wit","year":"2016","journal-title":"Eur j Endocrinol."},{"issue":"5","key":"2021120108534909400_CIT0024","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000444525","article-title":"Early detection, referral, investigation, and diagnosis of children with growth disorders","volume":"85","author":"Savage","year":"2016","journal-title":"Horm Res Paediatr."},{"issue":"9","key":"2021120108534909400_CIT0025","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1210\/jc.2005-0995","article-title":"PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome","volume":"90","author":"Binder","year":"2005","journal-title":"j Clin Endocrinol Metab."},{"issue":"2","key":"2021120108534909400_CIT0026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-14-0541","article-title":"Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: diagnostic value of serum IGF1 and height at presentation","volume":"172","author":"Storr","year":"2015","journal-title":"Eur j Endocrinol."},{"issue":"11","key":"2021120108534909400_CIT0027","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1210\/jc.2008-0509","article-title":"Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop","volume":"93","author":"Cohen","year":"2008","journal-title":"j Clin Endocrinol Metab."},{"issue":"6","key":"2021120108534909400_CIT0028","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-17-0453","article-title":"Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity","volume":"177","author":"Shapiro","year":"2017","journal-title":"Eur j Endocrinol."},{"issue":"3","key":"2021120108534909400_CIT0029","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12687-011-0072-y","article-title":"Consanguineous marriages: Preconception consultation in primary health care settings","volume":"3","author":"Hamamy","year":"2012","journal-title":"j Community Genet."},{"issue":"2","key":"2021120108534909400_CIT0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1399-0004.2001.600201.x","article-title":"Consanguinity and its relevance to clinical genetics","volume":"60","author":"Bittles","year":"2001","journal-title":"Clin Genet."},{"issue":"3","key":"2021120108534909400_CIT0031","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/EJE-11-0618","article-title":"Diagnosis of endocrine disease: limitations of the IGF1 generation test in children with short stature","volume":"166","author":"Coutant","year":"2012","journal-title":"Eur j Endocrinol."},{"key":"2021120108534909400_CIT0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atg.2015.08.002","article-title":"Empowered genome community: leveraging a bioinformatics platform as a citizen-scientist collaboration tool","volume":"6","author":"Wendelsdorf","year":"2015","journal-title":"Appl Transl Genom."},{"issue":"9","key":"2021120108534909400_CIT0033","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1093\/nar\/gkp215","article-title":"Human Splicing Finder: an online bioinformatics tool to predict splicing signals","volume":"37","author":"Desmet","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"2021120108534909400_CIT0034","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejmg.2010.10.010","article-title":"Detection of mosaicism for genome imbalance in a cohort of 3042 clinical cases using an oligonucleotide array CGH platform","volume":"54","author":"Hoang","year":"2011","journal-title":"Eur j Med Genet."},{"key":"2021120108534909400_CIT0035","volume-title":"ACGS best practice guidelines for variant classification 2017.","author":"Ellard","year":"2017"},{"issue":"6","key":"2021120108534909400_CIT0036","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ajhg.2009.04.021","article-title":"The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1","volume":"84","author":"Hanson","year":"2009","journal-title":"Am j Hum Genet."},{"issue":"1","key":"2021120108534909400_CIT0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000360857","article-title":"Whole exome sequencing to identify genetic causes of short stature","volume":"82","author":"Guo","year":"2014","journal-title":"Horm Res Paediatr."},{"issue":"1","key":"2021120108534909400_CIT0038","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2011.12.051","article-title":"3M syndrome: an easily recognizable yet underdiagnosed cause of proportionate short stature","volume":"161","author":"Al-Dosari","year":"2012","journal-title":"J Pediatr."},{"issue":"1","key":"2021120108534909400_CIT0039","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajhg.2011.05.028","article-title":"Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth","volume":"89","author":"Hanson","year":"2011","journal-title":"Am j Hum Genet."},{"issue":"6","key":"2021120108534909400_CIT0040","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am j Hum Genet."},{"issue":"8","key":"2021120108534909400_CIT0041","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/humu.20501","article-title":"Syndrome-causing mutations of the BLM gene in persons in the Bloom\u2019s Syndrome Registry","volume":"28","author":"German","year":"2007","journal-title":"Hum Mutat."},{"issue":"2","key":"2021120108534909400_CIT0042","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell."},{"issue":"5864","key":"2021120108534909400_CIT0043","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1151174","article-title":"Mutations in the pericentrin (PCNT) gene cause primordial dwarfism","volume":"319","author":"Rauch","year":"2008","journal-title":"Science."},{"issue":"1","key":"2021120108534909400_CIT0044","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/302700","article-title":"Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance","volume":"66","author":"Sperandeo","year":"2000","journal-title":"Am j Hum Genet."},{"issue":"10","key":"2021120108534909400_CIT0045","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ng1628","article-title":"Identification of mutations in CUL7 in 3-M syndrome","volume":"37","author":"Huber","year":"2005","journal-title":"Nat Genet."},{"issue":"6","key":"2021120108534909400_CIT0046","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1530\/EJE-20-0474","article-title":"Rare CNVs provide novel insights into the molecular basis of GH and IGF-1 Insensitivity","volume":"183","author":"Cottrell","year":"2020","journal-title":"Euro J Endocrinol."},{"key":"2021120108534909400_CIT0047","article-title":"The value of whole exome sequencing for genetic diagnosis in a patient with Bloom syndrome","author":"Cottrell","year":"2020","journal-title":"J Endocrinol Invest."},{"issue":"2","key":"2021120108534909400_CIT0048","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ghir.2007.11.004","article-title":"Idiopathic short stature: definition, epidemiology, and diagnostic evaluation","volume":"18","author":"Wit","year":"2008","journal-title":"Growth Horm igf Res."},{"issue":"3","key":"2021120108534909400_CIT0049","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2265.2012.04428.x","article-title":"Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination","volume":"77","author":"Clayton","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"2021120108534909400_CIT0050","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2011.32","article-title":"Clinical utility gene card for: 3M syndrome","volume":"19","author":"Holder-Espinasse","year":"2011","journal-title":"Eur J Hum Genet."},{"issue":"2","key":"2021120108534909400_CIT0051","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrendo.2016.138","article-title":"Diagnosis and management of Silver-Russell syndrome: first international consensus statement","volume":"13","author":"Wakeling","year":"2017","journal-title":"Nat Rev Endocrinol."},{"issue":"3","key":"2021120108534909400_CIT0052","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/14737159.4.3.393","article-title":"Clinical features of Bloom syndrome and function of the causative gene, BLM helicase","volume":"4","author":"Kaneko","year":"2004","journal-title":"Expert Rev Mol Diagn."},{"issue":"2","key":"2021120108534909400_CIT0053","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajhg.2009.07.001","article-title":"RIN2 deficiency results in macrocephaly, alopecia, cutis laxa, and scoliosis: MACS syndrome","volume":"85","author":"Basel-Vanagaite","year":"2009","journal-title":"Am j Hum Genet."},{"issue":"8","key":"2021120108534909400_CIT0054","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1210\/jc.2018-02065","article-title":"Phenotypic features and response to GH treatment of patients with a molecular defect of the IGF-1 receptor","volume":"104","author":"Walenkamp","year":"2019","journal-title":"j Clin Endocrinol Metab."},{"issue":"12","key":"2021120108534909400_CIT0055","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/jmg.2009.067298","article-title":"Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel\/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families","volume":"47","author":"Willems","year":"2010","journal-title":"j Med Genet."},{"issue":"3","key":"2021120108534909400_CIT0056","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2020.10.004","article-title":"Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX","volume":"131","author":"Fernandes","year":"2020","journal-title":"Mol Genet Metab."},{"issue":"1-2","key":"2021120108534909400_CIT0057","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","article-title":"Glycogen storage disease type IX: High variability in clinical phenotype","volume":"92","author":"Beauchamp","year":"2007","journal-title":"Mol Genet Metab."},{"issue":"2","key":"2021120108534909400_CIT0058","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2009.07991.x","article-title":"Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)","volume":"148","author":"Teachey","year":"2010","journal-title":"Br J Haematol."},{"issue":"10","key":"2021120108534909400_CIT0059","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/pd.2599","article-title":"Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth","volume":"30","author":"Steward","year":"2010","journal-title":"Prenat Diagn."},{"issue":"1","key":"2021120108534909400_CIT0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-9255-9-25","article-title":"Higher IL-6 and IL6:IGF ratio in patients with Barth syndrome","volume":"9","author":"Wilson","year":"2012","journal-title":"J Inflamm."},{"issue":"1","key":"2021120108534909400_CIT0061","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13023-016-0550-8","article-title":"Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood","volume":"12","author":"Mauhin","year":"2017","journal-title":"Orphanet J Rare Dis."},{"issue":"4","key":"2021120108534909400_CIT0062","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/342719","article-title":"Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies","volume":"71","author":"Ferreiro","year":"2002","journal-title":"Am J Hum Genet."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab437\/40436857\/dgab437.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/11\/e4716\/41378735\/dgab437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/11\/e4716\/41378735\/dgab437.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:41:21Z","timestamp":1638366081000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/11\/e4716\/6301140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":62,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6,16]]},"published-print":{"date-parts":[[2021,10,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab437","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,6,16]]}}}